CONDENSED CONSOLIDATED BALANCE SHEETS - USD ($)	Mar. 31, 2022	Sep. 30, 2021
Current assets:
Cash and cash equivalents	$ 6,512,784	$ 6,554,948
Accounts receivable, net of allowance of $39,821 and $29,821 at March 31, 2022 and September 30, 2021, respectively	2,587,811	2,804,039
Inventories	1,410,952	1,369,933
Prepaid expenses and other current assets	643,968	568,881
Total current assets	11,155,515	11,297,801
Property and equipment, net	2,628,697	3,023,915
Other assets:
Deposits	95,018	95,040
Total assets	13,879,230	14,416,756
Current liabilities:
Accounts payable and accrued liabilities	3,239,701	2,991,343
Deferred revenue	393,656	281,000
Total current liabilities	3,633,357	3,272,343
Long term accrued liabilities	31,467	31,467
Common Warrant liability	2,567,900
Total liabilities	6,232,724	3,303,810
Commitments and contingencies (Note G)
Applied DNA Sciences, Inc. stockholders' equity:
Preferred stock, par value $0.001 per share; 10,000,000 shares authorized; -0- shares issued and outstanding as of March 31, 2022 and September 30, 2021, respectively	0	0
Common stock, par value $0.001 per share; 200,000,000 shares authorized as of March 31, 2022 and September 30, 2021, 8,234,320 and 7,486,120 shares issued and outstanding as of March 31, 2022 and September 30, 2021, respectively	8,236	7,488
Additional paid in capital	298,351,897	295,228,272
Accumulated deficit	(290,712,648)	(284,122,092)
Applied DNA Sciences, Inc. stockholders' equity:	7,647,485	11,113,668
Noncontrolling interest	(979)	(722)
Total equity	7,646,506	11,112,946
Total liabilities and equity	13,879,230	14,416,756
Series A Preferred Stock [Member]
Applied DNA Sciences, Inc. stockholders' equity:
Preferred stock, par value $0.001 per share; 10,000,000 shares authorized; -0- shares issued and outstanding as of March 31, 2022 and September 30, 2021, respectively	0	0
Series B Preferred Stock [Member]
Applied DNA Sciences, Inc. stockholders' equity:
Preferred stock, par value $0.001 per share; 10,000,000 shares authorized; -0- shares issued and outstanding as of March 31, 2022 and September 30, 2021, respectively	$ 0	$ 0

Sum of the carrying values as of the balance sheet date of obligations incurred through that date and due within one year (or the operating cycle, if longer), including liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received, taxes, interest, rent and utilities, accrued salaries and bonuses, payroll taxes and fringe benefits.

Name:	us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent
Namespace Prefix:	us-gaap_
Data Type:	xbrli:monetaryItemType
Balance Type:	credit
Period Type:	instant

- Definition

Sum of the carrying values as of the balance sheet date of obligations incurred through that date and due after one year (or beyond the operating cycle if longer), including liabilities for compensation costs, fringe benefits other than pension and postretirement obligations, rent, contractual rights and obligations, and statutory obligations.